# Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery

> **NCT02293031** · NA · UNKNOWN · sponsor: **NextGen Company Limited** · enrollment: 12 (estimated)

## Conditions studied

- Maxillofacial Bone Defects
- Alveolar Bone Atrophy
- Jaw Fractures
- Maxillofacial Bone Deformities
- Bone Neoplasm, Benign
- Disorders of Teeth and Jaw

## Interventions

- **DEVICE:** Gene-activated matrix "Nucleostim"

## Key facts

- **NCT ID:** NCT02293031
- **Lead sponsor:** NextGen Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2017-08
- **Final completion:** 2017-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2017-03-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02293031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02293031, "Gene-activated Matrix for Bone Tissue Repair in Maxillofacial Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02293031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*